Vanguard Group Inc Sarepta Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,160,179 shares of SRPT stock, worth $220 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,160,179

Previous 9,032,613 1.41%

Holding current value

$220 Million

Previous $576 Million 72.83%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$17.1 - $63.66 $2.18 Million - $8.12 Million	127,566 Added 1.41%	9,160,179 $157 Million
Q1 2025 May 09, 2025	SELL	$63.82 - $127.89 $3.37 Million - $6.76 Million	-52,843 Reduced 0.58%	9,032,613 $576 Million
Q4 2024 Feb 11, 2025	BUY	$104.54 - $137.94 $12.3 Million - $16.3 Million	117,904 Added 1.31%	9,085,456 $1.1 Billion
Q3 2024 Nov 13, 2024	SELL	$124.33 - $156.75 $8.46 Million - $10.7 Million	-68,072 Reduced 0.75%	8,967,552 $1.12 Billion
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $27.2 Million - $39.3 Million	239,870 Added 2.73%	9,035,624 $1.43 Billion
Q1 2024 May 10, 2024	SELL	$93.7 - $141.53 $1.91 Million - $2.88 Million	-20,370 Reduced 0.23%	8,795,754 $1.14 Billion
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $16.4 Million - $30.3 Million	243,180 Added 2.84%	8,816,124 $850 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $4.25 Million - $5.12 Million	41,465 Added 0.49%	8,572,944 $1.04 Billion
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $44.5 Million - $65.8 Million	418,515 Added 5.16%	8,531,479 $977 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $9.37 Million - $12.4 Million	79,700 Added 0.99%	8,112,964 $1.12 Billion
Q4 2022 Feb 10, 2023	SELL	$100.86 - $132.13 $5.27 Million - $6.9 Million	-52,253 Reduced 0.65%	8,033,264 $1.04 Billion
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $25.3 Million - $39.9 Million	-334,530 Reduced 3.97%	8,085,517 $894 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $6.57 Million - $9.27 Million	104,865 Added 1.26%	8,420,047 $631 Million
Q1 2022 May 13, 2022	BUY	$63.15 - $90.42 $257,273 - $368,371	4,074 Added 0.05%	8,315,182 $650 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $64.2 Million - $82.6 Million	830,457 Added 11.1%	8,311,108 $748 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $1.6 Million - $2.24 Million	24,249 Added 0.33%	7,480,651 $692 Million
Q2 2021 Aug 13, 2021	BUY	$69.38 - $86.75 $517 Million - $647 Million	7,456,402 New	7,456,402 $580 Million

Others Institutions Holding SRPT

# of Institutions

449

Shares Held

82.1M

Call Options Held

5.6M

Put Options Held

4.17M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $2.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Sarepta Therapeutics, Inc. Transaction History